Keywords: amarillo, gets, orphan, drug, status, veldona, biosciences

Amarillo gets orphan drug status for Veldona

Article | 23 August 2000

Amarillo Biosciences has been granted orphan drug designation for itslow-dose orally-administered formulation of alpha interferon, Veldona, in the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Alpha

Prolastin

Nystatin

Go to drug listing